Skip to main content
logo
Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
41.04
+0.19 (0.47%)
At close: Jul 10, 2026, 4:00 PM EDT
40.00
-1.04 (-2.53%)
After-hours: Jul 10, 2026, 7:20 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Front Line Care Revenue
6.61B6.51B6.09B
Front Line Care Revenue Growth
1.47%7.00%4.16%
Surgical Solutions Revenue
6.35B6.17B5.47B
Surgical Solutions Revenue Growth
2.92%12.70%10.95%
Laboratory and Diagnostics Revenue
1.11B1.04B956.00M
Laboratory and Diagnostics Revenue Growth
6.35%8.79%14.22%
Medline Brand Revenue
13.91B13.72B12.52B
Medline Brand Revenue Growth
1.35%9.63%7.77%
Supply Chain Solutions Revenue
15.15B14.71B12.99B
Supply Chain Solutions Revenue Growth
2.95%13.24%11.83%
Revenue (Other)
89.00M--
Revenue (Total)
29.14B28.43B25.51B
Revenue (Total) Growth
2.49%11.47%9.80%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
United States Revenue
27.00B26.48B23.75B
United States Revenue Growth
1.96%11.51%8.93%
International Revenue
1.95B1.95B1.76B
International Revenue Growth
-0.05%10.97%22.99%
Revenue (Other)
189.00M--
Revenue (Total)
29.14B28.43B25.51B
Revenue (Total) Growth
2.49%11.47%9.80%

Adjusted EBITDA

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Medline Brand Adjusted EBITDA
3.20B3.33B3.27B
Medline Brand Adjusted EBITDA Growth
-3.93%1.99%20.89%
Supply Chain Solutions Adjusted EBITDA
777.00M805.00M647.00M
Supply Chain Solutions Adjusted EBITDA Growth
-3.48%24.42%31.77%
Operating Income (Total)
2.06B2.21B2.15B
Operating Income (Total) Growth
-6.74%3.08%71.68%